Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01813123 · ClinicalTrials.gov registry record · NA
A Web-Based Intervention to Prevent Drug Abuse Among Adolescent Girls
A NA study of Drug Abuse Prevention, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 788
- Enrollment target
- 1
- Study location
NCT01813123: Completed NA study of Drug Abuse Prevention, sponsored by Columbia University.
NCT01813123 is a NA study of Drug Abuse Prevention that has completed, run by Columbia University. The registered enrollment target is 788 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01813123, a NA study of Drug Abuse Prevention, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 788 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to develop and test a gender-specific, web-based drug abuse prevention program. Study participants will be adolescent girls aged 13 and 14 years who will complete all measures online. Randomly assigned girls will also interact online with a skills-based program and subsequent annual booster sessions. The study's primary hypothesis is that rates of 30-day alcohol and drug use will be lower among girls assigned to receive the intervention.
Primary Outcome
Measures will ask girls to report, for the past 30 days, the number of: drinks of alcohol consumed, cigarettes smoked, puffs of marijuana, and times they consumed four or more drinks within 2 hours. Girls will also report past 30-day use of: inhalants, ecstasy, club drugs, prescription drugs for recreational use, heroin, and hallucinogens.
Conditions Studied
Interventions
- BEHAVIORAL RealTeen
Study Locations (1)
New York
- Columbia University School of Social Work - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 788 participants |
| Start Date | 2013-03 |
| Est. Completion | 2019-01-30 |
| Phase | NA |
What the finished NCT01813123 record still lists
NCT01813123 is an interventional study that assigns participants to a tested intervention. The registered 788 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% lower).
The record links to 1 condition, with Drug Abuse Prevention appearing as the primary indexed condition, and to 1 intervention - of which RealTeen is the first listed.
NCT01813123 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01813123 about?
NCT01813123 is a clinical study titled "A Web-Based Intervention to Prevent Drug Abuse Among Adolescent Girls". This study is designed to develop and test a gender-specific, web-based drug abuse prevention program. Study participants will be adolescent girls aged 13 and 14 years who will complete all measures online. Randomly assigned girls will also interact online with a skills-based program and subsequent ...
What is the current status of trial NCT01813123?
This trial is currently completed. It is a NA study. The enrollment target is 788 participants. The study started on 2013-03. Estimated completion is 2019-01-30.
What conditions does trial NCT01813123 study?
This clinical trial studies the following conditions: Drug Abuse Prevention.
What interventions are being tested in trial NCT01813123?
The interventions under investigation include: RealTeen (BEHAVIORAL).
Who is sponsoring clinical trial NCT01813123?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01813123 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01813123's enrollment target sits among peer trials
788 141st of 2000 higher than 1,860 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06488781 · 787 participants · Phase 2
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0
- NCT06876649 · 787 participants · Phase 4
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
- NCT04967989 · 790 participants · Phase 3
Clarifying the Optimal Application of SLT Therapy Trial
- NCT06162611 · 790 participants · Phase 4
Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia